Legislation Mandating Insurance Coverage for Biomarker Testing Introduced in Massachusetts

Massachusetts could become the 10th US state to pass legislation requiring that certain insurance plans cover biomarker testing for patients when supported by medical and scientific evidence.

A pair of bills working their way through the Massachusetts Senate and House seek to mitigate coverage gaps for patients in the state, where currently some payors cover biomarker testing and some do not, said Marc Hymovitz, director of government relationships for Massachusetts at American Cancer Society Cancer Action Network (ACS CAN). “We put together legislation that will hopefully bridge those gaps and [lead to] clearer, understandable, and across-the-board insurance coverage policy when it comes to biomarker testing,” he said.

Source: https://www.precisionmedicineonline.com/precision-oncology/legislation-mandating-insurance-coverage-biomarker-testing-introduced